MRD (Minimal Residual Disease) Testing Market - Global Outlook and Forecast 2021-2027
This report contains market size and forecasts of MRD (Minimal Residual Disease) Testing in global, including the following market information:
Global MRD (Minimal Residual Disease) Testing Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global MRD (Minimal Residual Disease) Testing Market Sales, 2016-2021, 2022-2027, (Units)
Global top five MRD (Minimal Residual Disease) Testing companies in 2020 (%)
The global MRD (Minimal Residual Disease) Testing market was valued at XX million in 2020 and is projected to reach US$ XX million by 2027, at a CAGR of XX% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the MRD (Minimal Residual Disease) Testing manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global MRD (Minimal Residual Disease) Testing Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (Units)
Global MRD (Minimal Residual Disease) Testing Market Segment Percentages, By Type, 2020 (%)
Global MRD (Minimal Residual Disease) Testing Market Segment Percentages, By Application, 2020 (%)
Global MRD (Minimal Residual Disease) Testing Market Segment Percentages, By Region and Country, 2020 (%)
The report also provides analysis of leading market participants including:
Key companies MRD (Minimal Residual Disease) Testing revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies MRD (Minimal Residual Disease) Testing revenues share in global market, 2020 (%)
Key companies MRD (Minimal Residual Disease) Testing sales in global market, 2016-2021 (Estimated), (Units)
Key companies MRD (Minimal Residual Disease) Testing sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Global MRD (Minimal Residual Disease) Testing Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global MRD (Minimal Residual Disease) Testing Market Sales, 2016-2021, 2022-2027, (Units)
Global top five MRD (Minimal Residual Disease) Testing companies in 2020 (%)
The global MRD (Minimal Residual Disease) Testing market was valued at XX million in 2020 and is projected to reach US$ XX million by 2027, at a CAGR of XX% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the MRD (Minimal Residual Disease) Testing manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global MRD (Minimal Residual Disease) Testing Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (Units)
Global MRD (Minimal Residual Disease) Testing Market Segment Percentages, By Type, 2020 (%)
- Flow Cytometry
- Polymerase Chain Reaction (PCR)
- Next-Generation Sequencing (NGS)
Global MRD (Minimal Residual Disease) Testing Market Segment Percentages, By Application, 2020 (%)
- Specialty Clinics and Hospitals
- Diagnostic Laboratories
- Research Institutions
Global MRD (Minimal Residual Disease) Testing Market Segment Percentages, By Region and Country, 2020 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies MRD (Minimal Residual Disease) Testing revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies MRD (Minimal Residual Disease) Testing revenues share in global market, 2020 (%)
Key companies MRD (Minimal Residual Disease) Testing sales in global market, 2016-2021 (Estimated), (Units)
Key companies MRD (Minimal Residual Disease) Testing sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
- ICON plc
- ArcherDX(Invitae)
- ARUP Laboratories
- Asuragen
- Cergentis B.V.
- Bio-Rad Laboratories
- Mission Bio
- Guardant Health
- Invivoscribe
- LabCorp
- Inivata
- Natera
- NeoGenomics Laboratories
- Opko Health
- Quest Diagnostics
- Sysmex Corporation
- Adaptive Biotechnologies
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 MRD (Minimal Residual Disease) Testing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global MRD (Minimal Residual Disease) Testing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL MRD (MINIMAL RESIDUAL DISEASE) TESTING OVERALL MARKET SIZE
2.1 Global MRD (Minimal Residual Disease) Testing Market Size: 2021 VS 2027
2.2 Global MRD (Minimal Residual Disease) Testing Revenue, Prospects & Forecasts: 2016-2027
2.3 Global MRD (Minimal Residual Disease) Testing Sales (Consumption): 2016-2027
3 COMPANY LANDSCAPE
3.1 Top MRD (Minimal Residual Disease) Testing Players in Global Market
3.2 Top Global MRD (Minimal Residual Disease) Testing Companies Ranked by Revenue
3.3 Global MRD (Minimal Residual Disease) Testing Revenue by Companies
3.4 Global MRD (Minimal Residual Disease) Testing Sales by Companies
3.5 Global MRD (Minimal Residual Disease) Testing Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 MRD (Minimal Residual Disease) Testing Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers MRD (Minimal Residual Disease) Testing Product Type
3.8 Tier 1, Tier 2 and Tier 3 MRD (Minimal Residual Disease) Testing Players in Global Market
3.8.1 List of Global Tier 1 MRD (Minimal Residual Disease) Testing Companies
3.8.2 List of Global Tier 2 and Tier 3 MRD (Minimal Residual Disease) Testing Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global MRD (Minimal Residual Disease) Testing Market Size Markets, 2021 & 2027
4.1.2 Flow Cytometry
4.1.3 Polymerase Chain Reaction (PCR)
4.1.4 Next-Generation Sequencing (NGS)
4.2 By Type - Global MRD (Minimal Residual Disease) Testing Revenue & Forecasts
4.2.1 By Type - Global MRD (Minimal Residual Disease) Testing Revenue, 2016-2021
4.2.2 By Type - Global MRD (Minimal Residual Disease) Testing Revenue, 2022-2027
4.2.3 By Type - Global MRD (Minimal Residual Disease) Testing Revenue Market Share, 2016-2027
4.3 By Type - Global MRD (Minimal Residual Disease) Testing Sales & Forecasts
4.3.1 By Type - Global MRD (Minimal Residual Disease) Testing Sales, 2016-2021
4.3.2 By Type - Global MRD (Minimal Residual Disease) Testing Sales, 2022-2027
4.3.3 By Type - Global MRD (Minimal Residual Disease) Testing Sales Market Share, 2016-2027
4.4 By Type - Global MRD (Minimal Residual Disease) Testing Price (Manufacturers Selling Prices), 2016-2027
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global MRD (Minimal Residual Disease) Testing Market Size, 2021 & 2027
5.1.2 Specialty Clinics and Hospitals
5.1.3 Diagnostic Laboratories
5.1.4 Research Institutions
5.2 By Application - Global MRD (Minimal Residual Disease) Testing Revenue & Forecasts
5.2.1 By Application - Global MRD (Minimal Residual Disease) Testing Revenue, 2016-2021
5.2.2 By Application - Global MRD (Minimal Residual Disease) Testing Revenue, 2022-2027
5.2.3 By Application - Global MRD (Minimal Residual Disease) Testing Revenue Market Share, 2016-2027
5.3 By Application - Global MRD (Minimal Residual Disease) Testing Sales & Forecasts
5.3.1 By Application - Global MRD (Minimal Residual Disease) Testing Sales, 2016-2021
5.3.2 By Application - Global MRD (Minimal Residual Disease) Testing Sales, 2022-2027
5.3.3 By Application - Global MRD (Minimal Residual Disease) Testing Sales Market Share, 2016-2027
5.4 By Application - Global MRD (Minimal Residual Disease) Testing Price (Manufacturers Selling Prices), 2016-2027
6 SIGHTS BY REGION
6.1 By Region - Global MRD (Minimal Residual Disease) Testing Market Size, 2021 & 2027
6.2 By Region - Global MRD (Minimal Residual Disease) Testing Revenue & Forecasts
6.2.1 By Region - Global MRD (Minimal Residual Disease) Testing Revenue, 2016-2021
6.2.2 By Region - Global MRD (Minimal Residual Disease) Testing Revenue, 2022-2027
6.2.3 By Region - Global MRD (Minimal Residual Disease) Testing Revenue Market Share, 2016-2027
6.3 By Region - Global MRD (Minimal Residual Disease) Testing Sales & Forecasts
6.3.1 By Region - Global MRD (Minimal Residual Disease) Testing Sales, 2016-2021
6.3.2 By Region - Global MRD (Minimal Residual Disease) Testing Sales, 2022-2027
6.3.3 By Region - Global MRD (Minimal Residual Disease) Testing Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America MRD (Minimal Residual Disease) Testing Revenue, 2016-2027
6.4.2 By Country - North America MRD (Minimal Residual Disease) Testing Sales, 2016-2027
6.4.3 US MRD (Minimal Residual Disease) Testing Market Size, 2016-2027
6.4.4 Canada MRD (Minimal Residual Disease) Testing Market Size, 2016-2027
6.4.5 Mexico MRD (Minimal Residual Disease) Testing Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe MRD (Minimal Residual Disease) Testing Revenue, 2016-2027
6.5.2 By Country - Europe MRD (Minimal Residual Disease) Testing Sales, 2016-2027
6.5.3 Germany MRD (Minimal Residual Disease) Testing Market Size, 2016-2027
6.5.4 France MRD (Minimal Residual Disease) Testing Market Size, 2016-2027
6.5.5 U.K. MRD (Minimal Residual Disease) Testing Market Size, 2016-2027
6.5.6 Italy MRD (Minimal Residual Disease) Testing Market Size, 2016-2027
6.5.7 Russia MRD (Minimal Residual Disease) Testing Market Size, 2016-2027
6.5.8 Nordic Countries MRD (Minimal Residual Disease) Testing Market Size, 2016-2027
6.5.9 Benelux MRD (Minimal Residual Disease) Testing Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia MRD (Minimal Residual Disease) Testing Revenue, 2016-2027
6.6.2 By Region - Asia MRD (Minimal Residual Disease) Testing Sales, 2016-2027
6.6.3 China MRD (Minimal Residual Disease) Testing Market Size, 2016-2027
6.6.4 Japan MRD (Minimal Residual Disease) Testing Market Size, 2016-2027
6.6.5 South Korea MRD (Minimal Residual Disease) Testing Market Size, 2016-2027
6.6.6 Southeast Asia MRD (Minimal Residual Disease) Testing Market Size, 2016-2027
6.6.7 India MRD (Minimal Residual Disease) Testing Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America MRD (Minimal Residual Disease) Testing Revenue, 2016-2027
6.7.2 By Country - South America MRD (Minimal Residual Disease) Testing Sales, 2016-2027
6.7.3 Brazil MRD (Minimal Residual Disease) Testing Market Size, 2016-2027
6.7.4 Argentina MRD (Minimal Residual Disease) Testing Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa MRD (Minimal Residual Disease) Testing Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa MRD (Minimal Residual Disease) Testing Sales, 2016-2027
6.8.3 Turkey MRD (Minimal Residual Disease) Testing Market Size, 2016-2027
6.8.4 Israel MRD (Minimal Residual Disease) Testing Market Size, 2016-2027
6.8.5 Saudi Arabia MRD (Minimal Residual Disease) Testing Market Size, 2016-2027
6.8.6 UAE MRD (Minimal Residual Disease) Testing Market Size, 2016-2027
7 MANUFACTURERS & BRANDS PROFILES
7.1 ICON plc
7.1.1 ICON plc Corporate Summary
7.1.2 ICON plc Business Overview
7.1.3 ICON plc MRD (Minimal Residual Disease) Testing Major Product Offerings
7.1.4 ICON plc MRD (Minimal Residual Disease) Testing Sales and Revenue in Global (2016-2021)
7.1.5 ICON plc Key News
7.2 ArcherDX(Invitae)
7.2.1 ArcherDX(Invitae) Corporate Summary
7.2.2 ArcherDX(Invitae) Business Overview
7.2.3 ArcherDX(Invitae) MRD (Minimal Residual Disease) Testing Major Product Offerings
7.2.4 ArcherDX(Invitae) MRD (Minimal Residual Disease) Testing Sales and Revenue in Global (2016-2021)
7.2.5 ArcherDX(Invitae) Key News
7.3 ARUP Laboratories
7.3.1 ARUP Laboratories Corporate Summary
7.3.2 ARUP Laboratories Business Overview
7.3.3 ARUP Laboratories MRD (Minimal Residual Disease) Testing Major Product Offerings
7.3.4 ARUP Laboratories MRD (Minimal Residual Disease) Testing Sales and Revenue in Global (2016-2021)
7.3.5 ARUP Laboratories Key News
7.4 Asuragen
7.4.1 Asuragen Corporate Summary
7.4.2 Asuragen Business Overview
7.4.3 Asuragen MRD (Minimal Residual Disease) Testing Major Product Offerings
7.4.4 Asuragen MRD (Minimal Residual Disease) Testing Sales and Revenue in Global (2016-2021)
7.4.5 Asuragen Key News
7.5 Cergentis B.V.
7.5.1 Cergentis B.V. Corporate Summary
7.5.2 Cergentis B.V. Business Overview
7.5.3 Cergentis B.V. MRD (Minimal Residual Disease) Testing Major Product Offerings
7.5.4 Cergentis B.V. MRD (Minimal Residual Disease) Testing Sales and Revenue in Global (2016-2021)
7.5.5 Cergentis B.V. Key News
7.6 Bio-Rad Laboratories
7.6.1 Bio-Rad Laboratories Corporate Summary
7.6.2 Bio-Rad Laboratories Business Overview
7.6.3 Bio-Rad Laboratories MRD (Minimal Residual Disease) Testing Major Product Offerings
7.6.4 Bio-Rad Laboratories MRD (Minimal Residual Disease) Testing Sales and Revenue in Global (2016-2021)
7.6.5 Bio-Rad Laboratories Key News
7.7 Mission Bio
7.7.1 Mission Bio Corporate Summary
7.7.2 Mission Bio Business Overview
7.7.3 Mission Bio MRD (Minimal Residual Disease) Testing Major Product Offerings
7.4.4 Mission Bio MRD (Minimal Residual Disease) Testing Sales and Revenue in Global (2016-2021)
7.7.5 Mission Bio Key News
7.8 Guardant Health
7.8.1 Guardant Health Corporate Summary
7.8.2 Guardant Health Business Overview
7.8.3 Guardant Health MRD (Minimal Residual Disease) Testing Major Product Offerings
7.8.4 Guardant Health MRD (Minimal Residual Disease) Testing Sales and Revenue in Global (2016-2021)
7.8.5 Guardant Health Key News
7.9 Invivoscribe
7.9.1 Invivoscribe Corporate Summary
7.9.2 Invivoscribe Business Overview
7.9.3 Invivoscribe MRD (Minimal Residual Disease) Testing Major Product Offerings
7.9.4 Invivoscribe MRD (Minimal Residual Disease) Testing Sales and Revenue in Global (2016-2021)
7.9.5 Invivoscribe Key News
7.10 LabCorp
7.10.1 LabCorp Corporate Summary
7.10.2 LabCorp Business Overview
7.10.3 LabCorp MRD (Minimal Residual Disease) Testing Major Product Offerings
7.10.4 LabCorp MRD (Minimal Residual Disease) Testing Sales and Revenue in Global (2016-2021)
7.10.5 LabCorp Key News
7.11 Inivata
7.11.1 Inivata Corporate Summary
7.11.2 Inivata MRD (Minimal Residual Disease) Testing Business Overview
7.11.3 Inivata MRD (Minimal Residual Disease) Testing Major Product Offerings
7.11.4 Inivata MRD (Minimal Residual Disease) Testing Sales and Revenue in Global (2016-2021)
7.11.5 Inivata Key News
7.12 Natera
7.12.1 Natera Corporate Summary
7.12.2 Natera MRD (Minimal Residual Disease) Testing Business Overview
7.12.3 Natera MRD (Minimal Residual Disease) Testing Major Product Offerings
7.12.4 Natera MRD (Minimal Residual Disease) Testing Sales and Revenue in Global (2016-2021)
7.12.5 Natera Key News
7.13 NeoGenomics Laboratories
7.13.1 NeoGenomics Laboratories Corporate Summary
7.13.2 NeoGenomics Laboratories MRD (Minimal Residual Disease) Testing Business Overview
7.13.3 NeoGenomics Laboratories MRD (Minimal Residual Disease) Testing Major Product Offerings
7.13.4 NeoGenomics Laboratories MRD (Minimal Residual Disease) Testing Sales and Revenue in Global (2016-2021)
7.13.5 NeoGenomics Laboratories Key News
7.14 Opko Health
7.14.1 Opko Health Corporate Summary
7.14.2 Opko Health Business Overview
7.14.3 Opko Health MRD (Minimal Residual Disease) Testing Major Product Offerings
7.14.4 Opko Health MRD (Minimal Residual Disease) Testing Sales and Revenue in Global (2016-2021)
7.14.5 Opko Health Key News
7.15 Quest Diagnostics
7.15.1 Quest Diagnostics Corporate Summary
7.15.2 Quest Diagnostics Business Overview
7.15.3 Quest Diagnostics MRD (Minimal Residual Disease) Testing Major Product Offerings
7.15.4 Quest Diagnostics MRD (Minimal Residual Disease) Testing Sales and Revenue in Global (2016-2021)
7.15.5 Quest Diagnostics Key News
7.16 Sysmex Corporation
7.16.1 Sysmex Corporation Corporate Summary
7.16.2 Sysmex Corporation Business Overview
7.16.3 Sysmex Corporation MRD (Minimal Residual Disease) Testing Major Product Offerings
7.16.4 Sysmex Corporation MRD (Minimal Residual Disease) Testing Sales and Revenue in Global (2016-2021)
7.16.5 Sysmex Corporation Key News
7.17 Adaptive Biotechnologies
7.17.1 Adaptive Biotechnologies Corporate Summary
7.17.2 Adaptive Biotechnologies Business Overview
7.17.3 Adaptive Biotechnologies MRD (Minimal Residual Disease) Testing Major Product Offerings
7.17.4 Adaptive Biotechnologies MRD (Minimal Residual Disease) Testing Sales and Revenue in Global (2016-2021)
7.17.5 Adaptive Biotechnologies Key News
8 GLOBAL MRD (MINIMAL RESIDUAL DISEASE) TESTING PRODUCTION CAPACITY, ANALYSIS
8.1 Global MRD (Minimal Residual Disease) Testing Production Capacity, 2016-2027
8.2 MRD (Minimal Residual Disease) Testing Production Capacity of Key Manufacturers in Global Market
8.3 Global MRD (Minimal Residual Disease) Testing Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 MRD (MINIMAL RESIDUAL DISEASE) TESTING SUPPLY CHAIN ANALYSIS
10.1 MRD (Minimal Residual Disease) Testing Industry Value Chain
10.2 MRD (Minimal Residual Disease) Testing Upstream Market
10.3 MRD (Minimal Residual Disease) Testing Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 MRD (Minimal Residual Disease) Testing Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 MRD (Minimal Residual Disease) Testing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global MRD (Minimal Residual Disease) Testing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL MRD (MINIMAL RESIDUAL DISEASE) TESTING OVERALL MARKET SIZE
2.1 Global MRD (Minimal Residual Disease) Testing Market Size: 2021 VS 2027
2.2 Global MRD (Minimal Residual Disease) Testing Revenue, Prospects & Forecasts: 2016-2027
2.3 Global MRD (Minimal Residual Disease) Testing Sales (Consumption): 2016-2027
3 COMPANY LANDSCAPE
3.1 Top MRD (Minimal Residual Disease) Testing Players in Global Market
3.2 Top Global MRD (Minimal Residual Disease) Testing Companies Ranked by Revenue
3.3 Global MRD (Minimal Residual Disease) Testing Revenue by Companies
3.4 Global MRD (Minimal Residual Disease) Testing Sales by Companies
3.5 Global MRD (Minimal Residual Disease) Testing Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 MRD (Minimal Residual Disease) Testing Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers MRD (Minimal Residual Disease) Testing Product Type
3.8 Tier 1, Tier 2 and Tier 3 MRD (Minimal Residual Disease) Testing Players in Global Market
3.8.1 List of Global Tier 1 MRD (Minimal Residual Disease) Testing Companies
3.8.2 List of Global Tier 2 and Tier 3 MRD (Minimal Residual Disease) Testing Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global MRD (Minimal Residual Disease) Testing Market Size Markets, 2021 & 2027
4.1.2 Flow Cytometry
4.1.3 Polymerase Chain Reaction (PCR)
4.1.4 Next-Generation Sequencing (NGS)
4.2 By Type - Global MRD (Minimal Residual Disease) Testing Revenue & Forecasts
4.2.1 By Type - Global MRD (Minimal Residual Disease) Testing Revenue, 2016-2021
4.2.2 By Type - Global MRD (Minimal Residual Disease) Testing Revenue, 2022-2027
4.2.3 By Type - Global MRD (Minimal Residual Disease) Testing Revenue Market Share, 2016-2027
4.3 By Type - Global MRD (Minimal Residual Disease) Testing Sales & Forecasts
4.3.1 By Type - Global MRD (Minimal Residual Disease) Testing Sales, 2016-2021
4.3.2 By Type - Global MRD (Minimal Residual Disease) Testing Sales, 2022-2027
4.3.3 By Type - Global MRD (Minimal Residual Disease) Testing Sales Market Share, 2016-2027
4.4 By Type - Global MRD (Minimal Residual Disease) Testing Price (Manufacturers Selling Prices), 2016-2027
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global MRD (Minimal Residual Disease) Testing Market Size, 2021 & 2027
5.1.2 Specialty Clinics and Hospitals
5.1.3 Diagnostic Laboratories
5.1.4 Research Institutions
5.2 By Application - Global MRD (Minimal Residual Disease) Testing Revenue & Forecasts
5.2.1 By Application - Global MRD (Minimal Residual Disease) Testing Revenue, 2016-2021
5.2.2 By Application - Global MRD (Minimal Residual Disease) Testing Revenue, 2022-2027
5.2.3 By Application - Global MRD (Minimal Residual Disease) Testing Revenue Market Share, 2016-2027
5.3 By Application - Global MRD (Minimal Residual Disease) Testing Sales & Forecasts
5.3.1 By Application - Global MRD (Minimal Residual Disease) Testing Sales, 2016-2021
5.3.2 By Application - Global MRD (Minimal Residual Disease) Testing Sales, 2022-2027
5.3.3 By Application - Global MRD (Minimal Residual Disease) Testing Sales Market Share, 2016-2027
5.4 By Application - Global MRD (Minimal Residual Disease) Testing Price (Manufacturers Selling Prices), 2016-2027
6 SIGHTS BY REGION
6.1 By Region - Global MRD (Minimal Residual Disease) Testing Market Size, 2021 & 2027
6.2 By Region - Global MRD (Minimal Residual Disease) Testing Revenue & Forecasts
6.2.1 By Region - Global MRD (Minimal Residual Disease) Testing Revenue, 2016-2021
6.2.2 By Region - Global MRD (Minimal Residual Disease) Testing Revenue, 2022-2027
6.2.3 By Region - Global MRD (Minimal Residual Disease) Testing Revenue Market Share, 2016-2027
6.3 By Region - Global MRD (Minimal Residual Disease) Testing Sales & Forecasts
6.3.1 By Region - Global MRD (Minimal Residual Disease) Testing Sales, 2016-2021
6.3.2 By Region - Global MRD (Minimal Residual Disease) Testing Sales, 2022-2027
6.3.3 By Region - Global MRD (Minimal Residual Disease) Testing Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America MRD (Minimal Residual Disease) Testing Revenue, 2016-2027
6.4.2 By Country - North America MRD (Minimal Residual Disease) Testing Sales, 2016-2027
6.4.3 US MRD (Minimal Residual Disease) Testing Market Size, 2016-2027
6.4.4 Canada MRD (Minimal Residual Disease) Testing Market Size, 2016-2027
6.4.5 Mexico MRD (Minimal Residual Disease) Testing Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe MRD (Minimal Residual Disease) Testing Revenue, 2016-2027
6.5.2 By Country - Europe MRD (Minimal Residual Disease) Testing Sales, 2016-2027
6.5.3 Germany MRD (Minimal Residual Disease) Testing Market Size, 2016-2027
6.5.4 France MRD (Minimal Residual Disease) Testing Market Size, 2016-2027
6.5.5 U.K. MRD (Minimal Residual Disease) Testing Market Size, 2016-2027
6.5.6 Italy MRD (Minimal Residual Disease) Testing Market Size, 2016-2027
6.5.7 Russia MRD (Minimal Residual Disease) Testing Market Size, 2016-2027
6.5.8 Nordic Countries MRD (Minimal Residual Disease) Testing Market Size, 2016-2027
6.5.9 Benelux MRD (Minimal Residual Disease) Testing Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia MRD (Minimal Residual Disease) Testing Revenue, 2016-2027
6.6.2 By Region - Asia MRD (Minimal Residual Disease) Testing Sales, 2016-2027
6.6.3 China MRD (Minimal Residual Disease) Testing Market Size, 2016-2027
6.6.4 Japan MRD (Minimal Residual Disease) Testing Market Size, 2016-2027
6.6.5 South Korea MRD (Minimal Residual Disease) Testing Market Size, 2016-2027
6.6.6 Southeast Asia MRD (Minimal Residual Disease) Testing Market Size, 2016-2027
6.6.7 India MRD (Minimal Residual Disease) Testing Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America MRD (Minimal Residual Disease) Testing Revenue, 2016-2027
6.7.2 By Country - South America MRD (Minimal Residual Disease) Testing Sales, 2016-2027
6.7.3 Brazil MRD (Minimal Residual Disease) Testing Market Size, 2016-2027
6.7.4 Argentina MRD (Minimal Residual Disease) Testing Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa MRD (Minimal Residual Disease) Testing Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa MRD (Minimal Residual Disease) Testing Sales, 2016-2027
6.8.3 Turkey MRD (Minimal Residual Disease) Testing Market Size, 2016-2027
6.8.4 Israel MRD (Minimal Residual Disease) Testing Market Size, 2016-2027
6.8.5 Saudi Arabia MRD (Minimal Residual Disease) Testing Market Size, 2016-2027
6.8.6 UAE MRD (Minimal Residual Disease) Testing Market Size, 2016-2027
7 MANUFACTURERS & BRANDS PROFILES
7.1 ICON plc
7.1.1 ICON plc Corporate Summary
7.1.2 ICON plc Business Overview
7.1.3 ICON plc MRD (Minimal Residual Disease) Testing Major Product Offerings
7.1.4 ICON plc MRD (Minimal Residual Disease) Testing Sales and Revenue in Global (2016-2021)
7.1.5 ICON plc Key News
7.2 ArcherDX(Invitae)
7.2.1 ArcherDX(Invitae) Corporate Summary
7.2.2 ArcherDX(Invitae) Business Overview
7.2.3 ArcherDX(Invitae) MRD (Minimal Residual Disease) Testing Major Product Offerings
7.2.4 ArcherDX(Invitae) MRD (Minimal Residual Disease) Testing Sales and Revenue in Global (2016-2021)
7.2.5 ArcherDX(Invitae) Key News
7.3 ARUP Laboratories
7.3.1 ARUP Laboratories Corporate Summary
7.3.2 ARUP Laboratories Business Overview
7.3.3 ARUP Laboratories MRD (Minimal Residual Disease) Testing Major Product Offerings
7.3.4 ARUP Laboratories MRD (Minimal Residual Disease) Testing Sales and Revenue in Global (2016-2021)
7.3.5 ARUP Laboratories Key News
7.4 Asuragen
7.4.1 Asuragen Corporate Summary
7.4.2 Asuragen Business Overview
7.4.3 Asuragen MRD (Minimal Residual Disease) Testing Major Product Offerings
7.4.4 Asuragen MRD (Minimal Residual Disease) Testing Sales and Revenue in Global (2016-2021)
7.4.5 Asuragen Key News
7.5 Cergentis B.V.
7.5.1 Cergentis B.V. Corporate Summary
7.5.2 Cergentis B.V. Business Overview
7.5.3 Cergentis B.V. MRD (Minimal Residual Disease) Testing Major Product Offerings
7.5.4 Cergentis B.V. MRD (Minimal Residual Disease) Testing Sales and Revenue in Global (2016-2021)
7.5.5 Cergentis B.V. Key News
7.6 Bio-Rad Laboratories
7.6.1 Bio-Rad Laboratories Corporate Summary
7.6.2 Bio-Rad Laboratories Business Overview
7.6.3 Bio-Rad Laboratories MRD (Minimal Residual Disease) Testing Major Product Offerings
7.6.4 Bio-Rad Laboratories MRD (Minimal Residual Disease) Testing Sales and Revenue in Global (2016-2021)
7.6.5 Bio-Rad Laboratories Key News
7.7 Mission Bio
7.7.1 Mission Bio Corporate Summary
7.7.2 Mission Bio Business Overview
7.7.3 Mission Bio MRD (Minimal Residual Disease) Testing Major Product Offerings
7.4.4 Mission Bio MRD (Minimal Residual Disease) Testing Sales and Revenue in Global (2016-2021)
7.7.5 Mission Bio Key News
7.8 Guardant Health
7.8.1 Guardant Health Corporate Summary
7.8.2 Guardant Health Business Overview
7.8.3 Guardant Health MRD (Minimal Residual Disease) Testing Major Product Offerings
7.8.4 Guardant Health MRD (Minimal Residual Disease) Testing Sales and Revenue in Global (2016-2021)
7.8.5 Guardant Health Key News
7.9 Invivoscribe
7.9.1 Invivoscribe Corporate Summary
7.9.2 Invivoscribe Business Overview
7.9.3 Invivoscribe MRD (Minimal Residual Disease) Testing Major Product Offerings
7.9.4 Invivoscribe MRD (Minimal Residual Disease) Testing Sales and Revenue in Global (2016-2021)
7.9.5 Invivoscribe Key News
7.10 LabCorp
7.10.1 LabCorp Corporate Summary
7.10.2 LabCorp Business Overview
7.10.3 LabCorp MRD (Minimal Residual Disease) Testing Major Product Offerings
7.10.4 LabCorp MRD (Minimal Residual Disease) Testing Sales and Revenue in Global (2016-2021)
7.10.5 LabCorp Key News
7.11 Inivata
7.11.1 Inivata Corporate Summary
7.11.2 Inivata MRD (Minimal Residual Disease) Testing Business Overview
7.11.3 Inivata MRD (Minimal Residual Disease) Testing Major Product Offerings
7.11.4 Inivata MRD (Minimal Residual Disease) Testing Sales and Revenue in Global (2016-2021)
7.11.5 Inivata Key News
7.12 Natera
7.12.1 Natera Corporate Summary
7.12.2 Natera MRD (Minimal Residual Disease) Testing Business Overview
7.12.3 Natera MRD (Minimal Residual Disease) Testing Major Product Offerings
7.12.4 Natera MRD (Minimal Residual Disease) Testing Sales and Revenue in Global (2016-2021)
7.12.5 Natera Key News
7.13 NeoGenomics Laboratories
7.13.1 NeoGenomics Laboratories Corporate Summary
7.13.2 NeoGenomics Laboratories MRD (Minimal Residual Disease) Testing Business Overview
7.13.3 NeoGenomics Laboratories MRD (Minimal Residual Disease) Testing Major Product Offerings
7.13.4 NeoGenomics Laboratories MRD (Minimal Residual Disease) Testing Sales and Revenue in Global (2016-2021)
7.13.5 NeoGenomics Laboratories Key News
7.14 Opko Health
7.14.1 Opko Health Corporate Summary
7.14.2 Opko Health Business Overview
7.14.3 Opko Health MRD (Minimal Residual Disease) Testing Major Product Offerings
7.14.4 Opko Health MRD (Minimal Residual Disease) Testing Sales and Revenue in Global (2016-2021)
7.14.5 Opko Health Key News
7.15 Quest Diagnostics
7.15.1 Quest Diagnostics Corporate Summary
7.15.2 Quest Diagnostics Business Overview
7.15.3 Quest Diagnostics MRD (Minimal Residual Disease) Testing Major Product Offerings
7.15.4 Quest Diagnostics MRD (Minimal Residual Disease) Testing Sales and Revenue in Global (2016-2021)
7.15.5 Quest Diagnostics Key News
7.16 Sysmex Corporation
7.16.1 Sysmex Corporation Corporate Summary
7.16.2 Sysmex Corporation Business Overview
7.16.3 Sysmex Corporation MRD (Minimal Residual Disease) Testing Major Product Offerings
7.16.4 Sysmex Corporation MRD (Minimal Residual Disease) Testing Sales and Revenue in Global (2016-2021)
7.16.5 Sysmex Corporation Key News
7.17 Adaptive Biotechnologies
7.17.1 Adaptive Biotechnologies Corporate Summary
7.17.2 Adaptive Biotechnologies Business Overview
7.17.3 Adaptive Biotechnologies MRD (Minimal Residual Disease) Testing Major Product Offerings
7.17.4 Adaptive Biotechnologies MRD (Minimal Residual Disease) Testing Sales and Revenue in Global (2016-2021)
7.17.5 Adaptive Biotechnologies Key News
8 GLOBAL MRD (MINIMAL RESIDUAL DISEASE) TESTING PRODUCTION CAPACITY, ANALYSIS
8.1 Global MRD (Minimal Residual Disease) Testing Production Capacity, 2016-2027
8.2 MRD (Minimal Residual Disease) Testing Production Capacity of Key Manufacturers in Global Market
8.3 Global MRD (Minimal Residual Disease) Testing Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 MRD (MINIMAL RESIDUAL DISEASE) TESTING SUPPLY CHAIN ANALYSIS
10.1 MRD (Minimal Residual Disease) Testing Industry Value Chain
10.2 MRD (Minimal Residual Disease) Testing Upstream Market
10.3 MRD (Minimal Residual Disease) Testing Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 MRD (Minimal Residual Disease) Testing Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of MRD (Minimal Residual Disease) Testing in Global Market
Table 2. Top MRD (Minimal Residual Disease) Testing Players in Global Market, Ranking by Revenue (2019)
Table 3. Global MRD (Minimal Residual Disease) Testing Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global MRD (Minimal Residual Disease) Testing Revenue Share by Companies, 2016-2021
Table 5. Global MRD (Minimal Residual Disease) Testing Sales by Companies, (Units), 2016-2021
Table 6. Global MRD (Minimal Residual Disease) Testing Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers MRD (Minimal Residual Disease) Testing Price (2016-2021) & (US$/Unit)
Table 8. Global Manufacturers MRD (Minimal Residual Disease) Testing Product Type
Table 9. List of Global Tier 1 MRD (Minimal Residual Disease) Testing Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 MRD (Minimal Residual Disease) Testing Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global MRD (Minimal Residual Disease) Testing Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Global MRD (Minimal Residual Disease) Testing Revenue (US$, Mn), 2016-2021
Table 13. By Type - Global MRD (Minimal Residual Disease) Testing Revenue (US$, Mn), 2022-2027
Table 14. By Type - Global MRD (Minimal Residual Disease) Testing Sales (Units), 2016-2021
Table 15. By Type - Global MRD (Minimal Residual Disease) Testing Sales (Units), 2022-2027
Table 16. By Application – Global MRD (Minimal Residual Disease) Testing Revenue, (US$, Mn), 2021 VS 2027
Table 17. By Application - Global MRD (Minimal Residual Disease) Testing Revenue (US$, Mn), 2016-2021
Table 18. By Application - Global MRD (Minimal Residual Disease) Testing Revenue (US$, Mn), 2022-2027
Table 19. By Application - Global MRD (Minimal Residual Disease) Testing Sales (Units), 2016-2021
Table 20. By Application - Global MRD (Minimal Residual Disease) Testing Sales (Units), 2022-2027
Table 21. By Region – Global MRD (Minimal Residual Disease) Testing Revenue, (US$, Mn), 2021 VS 2027
Table 22. By Region - Global MRD (Minimal Residual Disease) Testing Revenue (US$, Mn), 2016-2021
Table 23. By Region - Global MRD (Minimal Residual Disease) Testing Revenue (US$, Mn), 2022-2027
Table 24. By Region - Global MRD (Minimal Residual Disease) Testing Sales (Units), 2016-2021
Table 25. By Region - Global MRD (Minimal Residual Disease) Testing Sales (Units), 2022-2027
Table 26. By Country - North America MRD (Minimal Residual Disease) Testing Revenue, (US$, Mn), 2016-2021
Table 27. By Country - North America MRD (Minimal Residual Disease) Testing Revenue, (US$, Mn), 2022-2027
Table 28. By Country - North America MRD (Minimal Residual Disease) Testing Sales, (Units), 2016-2021
Table 29. By Country - North America MRD (Minimal Residual Disease) Testing Sales, (Units), 2022-2027
Table 30. By Country - Europe MRD (Minimal Residual Disease) Testing Revenue, (US$, Mn), 2016-2021
Table 31. By Country - Europe MRD (Minimal Residual Disease) Testing Revenue, (US$, Mn), 2022-2027
Table 32. By Country - Europe MRD (Minimal Residual Disease) Testing Sales, (Units), 2016-2021
Table 33. By Country - Europe MRD (Minimal Residual Disease) Testing Sales, (Units), 2022-2027
Table 34. By Region - Asia MRD (Minimal Residual Disease) Testing Revenue, (US$, Mn), 2016-2021
Table 35. By Region - Asia MRD (Minimal Residual Disease) Testing Revenue, (US$, Mn), 2022-2027
Table 36. By Region - Asia MRD (Minimal Residual Disease) Testing Sales, (Units), 2016-2021
Table 37. By Region - Asia MRD (Minimal Residual Disease) Testing Sales, (Units), 2022-2027
Table 38. By Country - South America MRD (Minimal Residual Disease) Testing Revenue, (US$, Mn), 2016-2021
Table 39. By Country - South America MRD (Minimal Residual Disease) Testing Revenue, (US$, Mn), 2022-2027
Table 40. By Country - South America MRD (Minimal Residual Disease) Testing Sales, (Units), 2016-2021
Table 41. By Country - South America MRD (Minimal Residual Disease) Testing Sales, (Units), 2022-2027
Table 42. By Country - Middle East & Africa MRD (Minimal Residual Disease) Testing Revenue, (US$, Mn), 2016-2021
Table 43. By Country - Middle East & Africa MRD (Minimal Residual Disease) Testing Revenue, (US$, Mn), 2022-2027
Table 44. By Country - Middle East & Africa MRD (Minimal Residual Disease) Testing Sales, (Units), 2016-2021
Table 45. By Country - Middle East & Africa MRD (Minimal Residual Disease) Testing Sales, (Units), 2022-2027
Table 46. ICON plc Corporate Summary
Table 47. ICON plc MRD (Minimal Residual Disease) Testing Product Offerings
Table 48. ICON plc MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 49. ArcherDX(Invitae) Corporate Summary
Table 50. ArcherDX(Invitae) MRD (Minimal Residual Disease) Testing Product Offerings
Table 51. ArcherDX(Invitae) MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 52. ARUP Laboratories Corporate Summary
Table 53. ARUP Laboratories MRD (Minimal Residual Disease) Testing Product Offerings
Table 54. ARUP Laboratories MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 55. Asuragen Corporate Summary
Table 56. Asuragen MRD (Minimal Residual Disease) Testing Product Offerings
Table 57. Asuragen MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 58. Cergentis B.V. Corporate Summary
Table 59. Cergentis B.V. MRD (Minimal Residual Disease) Testing Product Offerings
Table 60. Cergentis B.V. MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 61. Bio-Rad Laboratories Corporate Summary
Table 62. Bio-Rad Laboratories MRD (Minimal Residual Disease) Testing Product Offerings
Table 63. Bio-Rad Laboratories MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 64. Mission Bio Corporate Summary
Table 65. Mission Bio MRD (Minimal Residual Disease) Testing Product Offerings
Table 66. Mission Bio MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 67. Guardant Health Corporate Summary
Table 68. Guardant Health MRD (Minimal Residual Disease) Testing Product Offerings
Table 69. Guardant Health MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 70. Invivoscribe Corporate Summary
Table 71. Invivoscribe MRD (Minimal Residual Disease) Testing Product Offerings
Table 72. Invivoscribe MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 73. LabCorp Corporate Summary
Table 74. LabCorp MRD (Minimal Residual Disease) Testing Product Offerings
Table 75. LabCorp MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 76. Inivata Corporate Summary
Table 77. Inivata MRD (Minimal Residual Disease) Testing Product Offerings
Table 78. Inivata MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 79. Natera Corporate Summary
Table 80. Natera MRD (Minimal Residual Disease) Testing Product Offerings
Table 81. Natera MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 82. NeoGenomics Laboratories Corporate Summary
Table 83. NeoGenomics Laboratories MRD (Minimal Residual Disease) Testing Product Offerings
Table 84. NeoGenomics Laboratories MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 85. Opko Health Corporate Summary
Table 86. Opko Health MRD (Minimal Residual Disease) Testing Product Offerings
Table 87. Opko Health MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 88. Quest Diagnostics Corporate Summary
Table 89. Quest Diagnostics MRD (Minimal Residual Disease) Testing Product Offerings
Table 90. Quest Diagnostics MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 91. Sysmex Corporation Corporate Summary
Table 92. Sysmex Corporation MRD (Minimal Residual Disease) Testing Product Offerings
Table 93. Sysmex Corporation MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 94. Adaptive Biotechnologies Corporate Summary
Table 95. Adaptive Biotechnologies MRD (Minimal Residual Disease) Testing Product Offerings
Table 96. Adaptive Biotechnologies MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 97. MRD (Minimal Residual Disease) Testing Production Capacity (Units) of Key Manufacturers in Global Market, 2019-2021 (Units)
Table 98. Global MRD (Minimal Residual Disease) Testing Capacity Market Share of Key Manufacturers, 2019-2021
Table 99. Global MRD (Minimal Residual Disease) Testing Production by Region, 2016-2021 (Units)
Table 100. Global MRD (Minimal Residual Disease) Testing Production by Region, 2022-2027 (Units)
Table 101. MRD (Minimal Residual Disease) Testing Market Opportunities & Trends in Global Market
Table 102. MRD (Minimal Residual Disease) Testing Market Drivers in Global Market
Table 103. MRD (Minimal Residual Disease) Testing Market Restraints in Global Market
Table 104. MRD (Minimal Residual Disease) Testing Raw Materials
Table 105. MRD (Minimal Residual Disease) Testing Raw Materials Suppliers in Global Market
Table 106. Typical MRD (Minimal Residual Disease) Testing Downstream
Table 107. MRD (Minimal Residual Disease) Testing Downstream Clients in Global Market
Table 108. MRD (Minimal Residual Disease) Testing Distributors and Sales Agents in Global Market
Table 1. Key Players of MRD (Minimal Residual Disease) Testing in Global Market
Table 2. Top MRD (Minimal Residual Disease) Testing Players in Global Market, Ranking by Revenue (2019)
Table 3. Global MRD (Minimal Residual Disease) Testing Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global MRD (Minimal Residual Disease) Testing Revenue Share by Companies, 2016-2021
Table 5. Global MRD (Minimal Residual Disease) Testing Sales by Companies, (Units), 2016-2021
Table 6. Global MRD (Minimal Residual Disease) Testing Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers MRD (Minimal Residual Disease) Testing Price (2016-2021) & (US$/Unit)
Table 8. Global Manufacturers MRD (Minimal Residual Disease) Testing Product Type
Table 9. List of Global Tier 1 MRD (Minimal Residual Disease) Testing Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 MRD (Minimal Residual Disease) Testing Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global MRD (Minimal Residual Disease) Testing Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Global MRD (Minimal Residual Disease) Testing Revenue (US$, Mn), 2016-2021
Table 13. By Type - Global MRD (Minimal Residual Disease) Testing Revenue (US$, Mn), 2022-2027
Table 14. By Type - Global MRD (Minimal Residual Disease) Testing Sales (Units), 2016-2021
Table 15. By Type - Global MRD (Minimal Residual Disease) Testing Sales (Units), 2022-2027
Table 16. By Application – Global MRD (Minimal Residual Disease) Testing Revenue, (US$, Mn), 2021 VS 2027
Table 17. By Application - Global MRD (Minimal Residual Disease) Testing Revenue (US$, Mn), 2016-2021
Table 18. By Application - Global MRD (Minimal Residual Disease) Testing Revenue (US$, Mn), 2022-2027
Table 19. By Application - Global MRD (Minimal Residual Disease) Testing Sales (Units), 2016-2021
Table 20. By Application - Global MRD (Minimal Residual Disease) Testing Sales (Units), 2022-2027
Table 21. By Region – Global MRD (Minimal Residual Disease) Testing Revenue, (US$, Mn), 2021 VS 2027
Table 22. By Region - Global MRD (Minimal Residual Disease) Testing Revenue (US$, Mn), 2016-2021
Table 23. By Region - Global MRD (Minimal Residual Disease) Testing Revenue (US$, Mn), 2022-2027
Table 24. By Region - Global MRD (Minimal Residual Disease) Testing Sales (Units), 2016-2021
Table 25. By Region - Global MRD (Minimal Residual Disease) Testing Sales (Units), 2022-2027
Table 26. By Country - North America MRD (Minimal Residual Disease) Testing Revenue, (US$, Mn), 2016-2021
Table 27. By Country - North America MRD (Minimal Residual Disease) Testing Revenue, (US$, Mn), 2022-2027
Table 28. By Country - North America MRD (Minimal Residual Disease) Testing Sales, (Units), 2016-2021
Table 29. By Country - North America MRD (Minimal Residual Disease) Testing Sales, (Units), 2022-2027
Table 30. By Country - Europe MRD (Minimal Residual Disease) Testing Revenue, (US$, Mn), 2016-2021
Table 31. By Country - Europe MRD (Minimal Residual Disease) Testing Revenue, (US$, Mn), 2022-2027
Table 32. By Country - Europe MRD (Minimal Residual Disease) Testing Sales, (Units), 2016-2021
Table 33. By Country - Europe MRD (Minimal Residual Disease) Testing Sales, (Units), 2022-2027
Table 34. By Region - Asia MRD (Minimal Residual Disease) Testing Revenue, (US$, Mn), 2016-2021
Table 35. By Region - Asia MRD (Minimal Residual Disease) Testing Revenue, (US$, Mn), 2022-2027
Table 36. By Region - Asia MRD (Minimal Residual Disease) Testing Sales, (Units), 2016-2021
Table 37. By Region - Asia MRD (Minimal Residual Disease) Testing Sales, (Units), 2022-2027
Table 38. By Country - South America MRD (Minimal Residual Disease) Testing Revenue, (US$, Mn), 2016-2021
Table 39. By Country - South America MRD (Minimal Residual Disease) Testing Revenue, (US$, Mn), 2022-2027
Table 40. By Country - South America MRD (Minimal Residual Disease) Testing Sales, (Units), 2016-2021
Table 41. By Country - South America MRD (Minimal Residual Disease) Testing Sales, (Units), 2022-2027
Table 42. By Country - Middle East & Africa MRD (Minimal Residual Disease) Testing Revenue, (US$, Mn), 2016-2021
Table 43. By Country - Middle East & Africa MRD (Minimal Residual Disease) Testing Revenue, (US$, Mn), 2022-2027
Table 44. By Country - Middle East & Africa MRD (Minimal Residual Disease) Testing Sales, (Units), 2016-2021
Table 45. By Country - Middle East & Africa MRD (Minimal Residual Disease) Testing Sales, (Units), 2022-2027
Table 46. ICON plc Corporate Summary
Table 47. ICON plc MRD (Minimal Residual Disease) Testing Product Offerings
Table 48. ICON plc MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 49. ArcherDX(Invitae) Corporate Summary
Table 50. ArcherDX(Invitae) MRD (Minimal Residual Disease) Testing Product Offerings
Table 51. ArcherDX(Invitae) MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 52. ARUP Laboratories Corporate Summary
Table 53. ARUP Laboratories MRD (Minimal Residual Disease) Testing Product Offerings
Table 54. ARUP Laboratories MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 55. Asuragen Corporate Summary
Table 56. Asuragen MRD (Minimal Residual Disease) Testing Product Offerings
Table 57. Asuragen MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 58. Cergentis B.V. Corporate Summary
Table 59. Cergentis B.V. MRD (Minimal Residual Disease) Testing Product Offerings
Table 60. Cergentis B.V. MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 61. Bio-Rad Laboratories Corporate Summary
Table 62. Bio-Rad Laboratories MRD (Minimal Residual Disease) Testing Product Offerings
Table 63. Bio-Rad Laboratories MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 64. Mission Bio Corporate Summary
Table 65. Mission Bio MRD (Minimal Residual Disease) Testing Product Offerings
Table 66. Mission Bio MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 67. Guardant Health Corporate Summary
Table 68. Guardant Health MRD (Minimal Residual Disease) Testing Product Offerings
Table 69. Guardant Health MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 70. Invivoscribe Corporate Summary
Table 71. Invivoscribe MRD (Minimal Residual Disease) Testing Product Offerings
Table 72. Invivoscribe MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 73. LabCorp Corporate Summary
Table 74. LabCorp MRD (Minimal Residual Disease) Testing Product Offerings
Table 75. LabCorp MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 76. Inivata Corporate Summary
Table 77. Inivata MRD (Minimal Residual Disease) Testing Product Offerings
Table 78. Inivata MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 79. Natera Corporate Summary
Table 80. Natera MRD (Minimal Residual Disease) Testing Product Offerings
Table 81. Natera MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 82. NeoGenomics Laboratories Corporate Summary
Table 83. NeoGenomics Laboratories MRD (Minimal Residual Disease) Testing Product Offerings
Table 84. NeoGenomics Laboratories MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 85. Opko Health Corporate Summary
Table 86. Opko Health MRD (Minimal Residual Disease) Testing Product Offerings
Table 87. Opko Health MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 88. Quest Diagnostics Corporate Summary
Table 89. Quest Diagnostics MRD (Minimal Residual Disease) Testing Product Offerings
Table 90. Quest Diagnostics MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 91. Sysmex Corporation Corporate Summary
Table 92. Sysmex Corporation MRD (Minimal Residual Disease) Testing Product Offerings
Table 93. Sysmex Corporation MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 94. Adaptive Biotechnologies Corporate Summary
Table 95. Adaptive Biotechnologies MRD (Minimal Residual Disease) Testing Product Offerings
Table 96. Adaptive Biotechnologies MRD (Minimal Residual Disease) Testing Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2016-2021)
Table 97. MRD (Minimal Residual Disease) Testing Production Capacity (Units) of Key Manufacturers in Global Market, 2019-2021 (Units)
Table 98. Global MRD (Minimal Residual Disease) Testing Capacity Market Share of Key Manufacturers, 2019-2021
Table 99. Global MRD (Minimal Residual Disease) Testing Production by Region, 2016-2021 (Units)
Table 100. Global MRD (Minimal Residual Disease) Testing Production by Region, 2022-2027 (Units)
Table 101. MRD (Minimal Residual Disease) Testing Market Opportunities & Trends in Global Market
Table 102. MRD (Minimal Residual Disease) Testing Market Drivers in Global Market
Table 103. MRD (Minimal Residual Disease) Testing Market Restraints in Global Market
Table 104. MRD (Minimal Residual Disease) Testing Raw Materials
Table 105. MRD (Minimal Residual Disease) Testing Raw Materials Suppliers in Global Market
Table 106. Typical MRD (Minimal Residual Disease) Testing Downstream
Table 107. MRD (Minimal Residual Disease) Testing Downstream Clients in Global Market
Table 108. MRD (Minimal Residual Disease) Testing Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. MRD (Minimal Residual Disease) Testing Segment by Type
Figure 2. MRD (Minimal Residual Disease) Testing Segment by Application
Figure 3. Global MRD (Minimal Residual Disease) Testing Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global MRD (Minimal Residual Disease) Testing Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global MRD (Minimal Residual Disease) Testing Revenue, 2016-2027 (US$, Mn)
Figure 7. MRD (Minimal Residual Disease) Testing Sales in Global Market: 2016-2027 (Units)
Figure 8. The Top 3 and 5 Players Market Share by MRD (Minimal Residual Disease) Testing Revenue in 2020
Figure 9. By Type - Global MRD (Minimal Residual Disease) Testing Sales Market Share, 2016-2027
Figure 10. By Type - Global MRD (Minimal Residual Disease) Testing Revenue Market Share, 2016-2027
Figure 11. By Type - Global MRD (Minimal Residual Disease) Testing Price (US$/Unit), 2016-2027
Figure 12. By Application - Global MRD (Minimal Residual Disease) Testing Sales Market Share, 2016-2027
Figure 13. By Application - Global MRD (Minimal Residual Disease) Testing Revenue Market Share, 2016-2027
Figure 14. By Application - Global MRD (Minimal Residual Disease) Testing Price (US$/Unit), 2016-2027
Figure 15. By Region - Global MRD (Minimal Residual Disease) Testing Sales Market Share, 2016-2027
Figure 16. By Region - Global MRD (Minimal Residual Disease) Testing Revenue Market Share, 2016-2027
Figure 17. By Country - North America MRD (Minimal Residual Disease) Testing Revenue Market Share, 2016-2027
Figure 18. By Country - North America MRD (Minimal Residual Disease) Testing Sales Market Share, 2016-2027
Figure 19. US MRD (Minimal Residual Disease) Testing Revenue, (US$, Mn), 2016-2027
Figure 20. Canada MRD (Minimal Residual Disease) Testing Revenue, (US$, Mn), 2016-2027
Figure 21. Mexico MRD (Minimal Residual Disease) Testing Revenue, (US$, Mn), 2016-2027
Figure 22. By Country - Europe MRD (Minimal Residual Disease) Testing Revenue Market Share, 2016-2027
Figure 23. By Country - Europe MRD (Minimal Residual Disease) Testing Sales Market Share, 2016-2027
Figure 24. Germany MRD (Minimal Residual Disease) Testing Revenue, (US$, Mn), 2016-2027
Figure 25. France MRD (Minimal Residual Disease) Testing Revenue, (US$, Mn), 2016-2027
Figure 26. U.K. MRD (Minimal Residual Disease) Testing Revenue, (US$, Mn), 2016-2027
Figure 27. Italy MRD (Minimal Residual Disease) Testing Revenue, (US$, Mn), 2016-2027
Figure 28. Russia MRD (Minimal Residual Disease) Testing Revenue, (US$, Mn), 2016-2027
Figure 29. Nordic Countries MRD (Minimal Residual Disease) Testing Revenue, (US$, Mn), 2016-2027
Figure 30. Benelux MRD (Minimal Residual Disease) Testing Revenue, (US$, Mn), 2016-2027
Figure 31. By Region - Asia MRD (Minimal Residual Disease) Testing Revenue Market Share, 2016-2027
Figure 32. By Region - Asia MRD (Minimal Residual Disease) Testing Sales Market Share, 2016-2027
Figure 33. China MRD (Minimal Residual Disease) Testing Revenue, (US$, Mn), 2016-2027
Figure 34. Japan MRD (Minimal Residual Disease) Testing Revenue, (US$, Mn), 2016-2027
Figure 35. South Korea MRD (Minimal Residual Disease) Testing Revenue, (US$, Mn), 2016-2027
Figure 36. Southeast Asia MRD (Minimal Residual Disease) Testing Revenue, (US$, Mn), 2016-2027
Figure 37. India MRD (Minimal Residual Disease) Testing Revenue, (US$, Mn), 2016-2027
Figure 38. By Country - South America MRD (Minimal Residual Disease) Testing Revenue Market Share, 2016-2027
Figure 39. By Country - South America MRD (Minimal Residual Disease) Testing Sales Market Share, 2016-2027
Figure 40. Brazil MRD (Minimal Residual Disease) Testing Revenue, (US$, Mn), 2016-2027
Figure 41. Argentina MRD (Minimal Residual Disease) Testing Revenue, (US$, Mn), 2016-2027
Figure 42. By Country - Middle East & Africa MRD (Minimal Residual Disease) Testing Revenue Market Share, 2016-2027
Figure 43. By Country - Middle East & Africa MRD (Minimal Residual Disease) Testing Sales Market Share, 2016-2027
Figure 44. Turkey MRD (Minimal Residual Disease) Testing Revenue, (US$, Mn), 2016-2027
Figure 45. Israel MRD (Minimal Residual Disease) Testing Revenue, (US$, Mn), 2016-2027
Figure 46. Saudi Arabia MRD (Minimal Residual Disease) Testing Revenue, (US$, Mn), 2016-2027
Figure 47. UAE MRD (Minimal Residual Disease) Testing Revenue, (US$, Mn), 2016-2027
Figure 48. Global MRD (Minimal Residual Disease) Testing Production Capacity (Units), 2016-2027
Figure 49. The Percentage of Production MRD (Minimal Residual Disease) Testing by Region, 2020 VS 2027
Figure 50. MRD (Minimal Residual Disease) Testing Industry Value Chain
Figure 51. Marketing Channels
Figure 1. MRD (Minimal Residual Disease) Testing Segment by Type
Figure 2. MRD (Minimal Residual Disease) Testing Segment by Application
Figure 3. Global MRD (Minimal Residual Disease) Testing Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global MRD (Minimal Residual Disease) Testing Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global MRD (Minimal Residual Disease) Testing Revenue, 2016-2027 (US$, Mn)
Figure 7. MRD (Minimal Residual Disease) Testing Sales in Global Market: 2016-2027 (Units)
Figure 8. The Top 3 and 5 Players Market Share by MRD (Minimal Residual Disease) Testing Revenue in 2020
Figure 9. By Type - Global MRD (Minimal Residual Disease) Testing Sales Market Share, 2016-2027
Figure 10. By Type - Global MRD (Minimal Residual Disease) Testing Revenue Market Share, 2016-2027
Figure 11. By Type - Global MRD (Minimal Residual Disease) Testing Price (US$/Unit), 2016-2027
Figure 12. By Application - Global MRD (Minimal Residual Disease) Testing Sales Market Share, 2016-2027
Figure 13. By Application - Global MRD (Minimal Residual Disease) Testing Revenue Market Share, 2016-2027
Figure 14. By Application - Global MRD (Minimal Residual Disease) Testing Price (US$/Unit), 2016-2027
Figure 15. By Region - Global MRD (Minimal Residual Disease) Testing Sales Market Share, 2016-2027
Figure 16. By Region - Global MRD (Minimal Residual Disease) Testing Revenue Market Share, 2016-2027
Figure 17. By Country - North America MRD (Minimal Residual Disease) Testing Revenue Market Share, 2016-2027
Figure 18. By Country - North America MRD (Minimal Residual Disease) Testing Sales Market Share, 2016-2027
Figure 19. US MRD (Minimal Residual Disease) Testing Revenue, (US$, Mn), 2016-2027
Figure 20. Canada MRD (Minimal Residual Disease) Testing Revenue, (US$, Mn), 2016-2027
Figure 21. Mexico MRD (Minimal Residual Disease) Testing Revenue, (US$, Mn), 2016-2027
Figure 22. By Country - Europe MRD (Minimal Residual Disease) Testing Revenue Market Share, 2016-2027
Figure 23. By Country - Europe MRD (Minimal Residual Disease) Testing Sales Market Share, 2016-2027
Figure 24. Germany MRD (Minimal Residual Disease) Testing Revenue, (US$, Mn), 2016-2027
Figure 25. France MRD (Minimal Residual Disease) Testing Revenue, (US$, Mn), 2016-2027
Figure 26. U.K. MRD (Minimal Residual Disease) Testing Revenue, (US$, Mn), 2016-2027
Figure 27. Italy MRD (Minimal Residual Disease) Testing Revenue, (US$, Mn), 2016-2027
Figure 28. Russia MRD (Minimal Residual Disease) Testing Revenue, (US$, Mn), 2016-2027
Figure 29. Nordic Countries MRD (Minimal Residual Disease) Testing Revenue, (US$, Mn), 2016-2027
Figure 30. Benelux MRD (Minimal Residual Disease) Testing Revenue, (US$, Mn), 2016-2027
Figure 31. By Region - Asia MRD (Minimal Residual Disease) Testing Revenue Market Share, 2016-2027
Figure 32. By Region - Asia MRD (Minimal Residual Disease) Testing Sales Market Share, 2016-2027
Figure 33. China MRD (Minimal Residual Disease) Testing Revenue, (US$, Mn), 2016-2027
Figure 34. Japan MRD (Minimal Residual Disease) Testing Revenue, (US$, Mn), 2016-2027
Figure 35. South Korea MRD (Minimal Residual Disease) Testing Revenue, (US$, Mn), 2016-2027
Figure 36. Southeast Asia MRD (Minimal Residual Disease) Testing Revenue, (US$, Mn), 2016-2027
Figure 37. India MRD (Minimal Residual Disease) Testing Revenue, (US$, Mn), 2016-2027
Figure 38. By Country - South America MRD (Minimal Residual Disease) Testing Revenue Market Share, 2016-2027
Figure 39. By Country - South America MRD (Minimal Residual Disease) Testing Sales Market Share, 2016-2027
Figure 40. Brazil MRD (Minimal Residual Disease) Testing Revenue, (US$, Mn), 2016-2027
Figure 41. Argentina MRD (Minimal Residual Disease) Testing Revenue, (US$, Mn), 2016-2027
Figure 42. By Country - Middle East & Africa MRD (Minimal Residual Disease) Testing Revenue Market Share, 2016-2027
Figure 43. By Country - Middle East & Africa MRD (Minimal Residual Disease) Testing Sales Market Share, 2016-2027
Figure 44. Turkey MRD (Minimal Residual Disease) Testing Revenue, (US$, Mn), 2016-2027
Figure 45. Israel MRD (Minimal Residual Disease) Testing Revenue, (US$, Mn), 2016-2027
Figure 46. Saudi Arabia MRD (Minimal Residual Disease) Testing Revenue, (US$, Mn), 2016-2027
Figure 47. UAE MRD (Minimal Residual Disease) Testing Revenue, (US$, Mn), 2016-2027
Figure 48. Global MRD (Minimal Residual Disease) Testing Production Capacity (Units), 2016-2027
Figure 49. The Percentage of Production MRD (Minimal Residual Disease) Testing by Region, 2020 VS 2027
Figure 50. MRD (Minimal Residual Disease) Testing Industry Value Chain
Figure 51. Marketing Channels
